Related Experiment Video
Updated: Jun 21, 2026
09:03
Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
Published on: June 30, 2023
Intermedin is a new angiogenic growth factor
Robert S Smith1, Lin Gao, Grant Bledsoe
1Department of Biochemistry, Medical University of South Carolina, Charleston, South Carolina 29425-2211, USA.
Summary
Intermedin (IMD) gene delivery significantly improved blood flow and vessel density in ischemic hindlimbs. IMD promotes angiogenesis by activating key signaling pathways, offering potential therapeutic benefits.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Regenerative Medicine
Background:
- Intermedin (IMD) is a peptide related to adrenomedullin.
- Previous studies showed IMD gene delivery prevented kidney damage.
- The role of IMD in angiogenesis in ischemic conditions was unexplored.
Purpose of the Study:
- To investigate the role of Intermedin (IMD) in promoting angiogenesis in an ischemic hindlimb model.
- To elucidate the molecular mechanisms underlying IMD-mediated angiogenesis.
Main Methods:
- Adenovirus-mediated IMD gene transfer in a rat hindlimb ischemia model.
- Laser-Doppler imaging to assess blood perfusion.
- Immunohistochemistry (CD-31, alpha-smooth muscle actin) for vessel density.
- In vitro studies using endothelial cells and Matrigel assays.
Main Results:
- IMD gene transfer significantly increased blood perfusion and vessel density (capillaries, arterioles) in ischemic hindlimbs.
- IMD peptide stimulated capillary formation and hemoglobin content in Matrigel implants.
- IMD enhanced endothelial cell migration and tube formation in vitro.
- IMD's effects involved activation of ERK, Akt, NOS, and VEGF/VEGFR-2 pathways.
Conclusions:
- Intermedin (IMD) effectively promotes angiogenesis in ischemic tissues.
- IMD acts through the ERK, Akt/NOS/NO, and VEGF/VEGFR-2 signaling cascades.
- IMD holds therapeutic potential for treating conditions involving endothelial dysfunction and ischemia.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...